Industry: Chemical & Material
Published Date: 2025-11-09
Pages: 109 Pages
Report ld: 5403991
Request Sample
Customized Report
The global Modafinil API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Modafinil API market competitiveness, regional economic performance, and supply chain configurations.
Modafinil(CAS:68693-11-8) is a central nervous system (CNS) stimulant medication used to treat sleepiness due to narcolepsy, shift work sleep disorder, and obstructive sleep apnea.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Modafinil API market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Modafinil API market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Above 99 % in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Others in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Modafinil API value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Modafinil API Product Scope
1.2 Modafinil API by Type
1.2.1 Global Modafinil API Sales by Type (2020 & 2024 & 2031)
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Modafinil API by Application
1.3.1 Global Modafinil API Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Tablets
1.3.3 Others
1.4 Global Modafinil API Market Estimates and Forecasts (2020-2031)
1.4.1 Global Modafinil API Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Modafinil API Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Modafinil API Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Modafinil API Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Modafinil API Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Modafinil API Sales Market Share by Region (2020-2025)
2.2.2 Global Modafinil API Revenue Market Share by Region (2020-2025)
2.3 Global Modafinil API Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Modafinil API Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Modafinil API Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Modafinil API Market Size and Prospective (2020-2031)
2.4.2 Europe Modafinil API Market Size and Prospective (2020-2031)
2.4.3 India Modafinil API Market Size and Prospective (2020-2031)
2.4.4 Israel Modafinil API Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Modafinil API Historic Market Review by Type (2020-2025)
3.1.1 Global Modafinil API Sales by Type (2020-2025)
3.1.2 Global Modafinil API Revenue by Type (2020-2025)
3.1.3 Global Modafinil API Price by Type (2020-2025)
3.2 Global Modafinil API Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Modafinil API Sales Forecast by Type (2026-2031)
3.2.2 Global Modafinil API Revenue Forecast by Type (2026-2031)
3.2.3 Global Modafinil API Price Forecast by Type (2026-2031)
3.3 Different Types Modafinil API Representative Players
4 Global Market Size by Application
4.1 Global Modafinil API Historic Market Review by Application (2020-2025)
4.1.1 Global Modafinil API Sales by Application (2020-2025)
4.1.2 Global Modafinil API Revenue by Application (2020-2025)
4.1.3 Global Modafinil API Price by Application (2020-2025)
4.2 Global Modafinil API Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Modafinil API Sales Forecast by Application (2026-2031)
4.2.2 Global Modafinil API Revenue Forecast by Application (2026-2031)
4.2.3 Global Modafinil API Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Modafinil API Application
5 Competition Landscape by Players
5.1 Global Modafinil API Sales by Players (2020-2025)
5.2 Global Top Modafinil API Players by Revenue (2020-2025)
5.3 Global Modafinil API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Modafinil API as of 2024)
5.4 Global Modafinil API Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Modafinil API, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Modafinil API, Product Type & Application
5.7 Global Key Manufacturers of Modafinil API, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Modafinil API Sales by Company
6.1.1.1 North America Modafinil API Sales by Company (2020-2025)
6.1.1.2 North America Modafinil API Revenue by Company (2020-2025)
6.1.2 North America Modafinil API Sales Breakdown by Type (2020-2025)
6.1.3 North America Modafinil API Sales Breakdown by Application (2020-2025)
6.1.4 North America Modafinil API Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Modafinil API Sales by Company
6.2.1.1 Europe Modafinil API Sales by Company (2020-2025)
6.2.1.2 Europe Modafinil API Revenue by Company (2020-2025)
6.2.2 Europe Modafinil API Sales Breakdown by Type (2020-2025)
6.2.3 Europe Modafinil API Sales Breakdown by Application (2020-2025)
6.2.4 Europe Modafinil API Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 India Market: Players, Segments, Downstream and Major Customers
6.3.1 India Modafinil API Sales by Company
6.3.1.1 India Modafinil API Sales by Company (2020-2025)
6.3.1.2 India Modafinil API Revenue by Company (2020-2025)
6.3.2 India Modafinil API Sales Breakdown by Type (2020-2025)
6.3.3 India Modafinil API Sales Breakdown by Application (2020-2025)
6.3.4 India Modafinil API Major Customer
6.3.5 India Market Trend and Opportunities
6.4 Israel Market: Players, Segments, Downstream and Major Customers
6.4.1 Israel Modafinil API Sales by Company
6.4.1.1 Israel Modafinil API Sales by Company (2020-2025)
6.4.1.2 Israel Modafinil API Revenue by Company (2020-2025)
6.4.2 Israel Modafinil API Sales Breakdown by Type (2020-2025)
6.4.3 Israel Modafinil API Sales Breakdown by Application (2020-2025)
6.4.4 Israel Modafinil API Major Customer
6.4.5 Israel Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Aurobindo Pharma Limited
7.1.1 Aurobindo Pharma Limited Company Information
7.1.2 Aurobindo Pharma Limited Business Overview
7.1.3 Aurobindo Pharma Limited Modafinil API Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Aurobindo Pharma Limited Modafinil API Products Offered
7.1.5 Aurobindo Pharma Limited Recent Development
7.2 Jai Radhe Sales
7.2.1 Jai Radhe Sales Company Information
7.2.2 Jai Radhe Sales Business Overview
7.2.3 Jai Radhe Sales Modafinil API Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Jai Radhe Sales Modafinil API Products Offered
7.2.5 Jai Radhe Sales Recent Development
7.3 Mylan
7.3.1 Mylan Company Information
7.3.2 Mylan Business Overview
7.3.3 Mylan Modafinil API Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Mylan Modafinil API Products Offered
7.3.5 Mylan Recent Development
7.4 Seqens
7.4.1 Seqens Company Information
7.4.2 Seqens Business Overview
7.4.3 Seqens Modafinil API Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Seqens Modafinil API Products Offered
7.4.5 Seqens Recent Development
7.5 Wavelength
7.5.1 Wavelength Company Information
7.5.2 Wavelength Business Overview
7.5.3 Wavelength Modafinil API Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Wavelength Modafinil API Products Offered
7.5.5 Wavelength Recent Development
7.6 Om Pharmaceutical Industries
7.6.1 Om Pharmaceutical Industries Company Information
7.6.2 Om Pharmaceutical Industries Business Overview
7.6.3 Om Pharmaceutical Industries Modafinil API Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Om Pharmaceutical Industries Modafinil API Products Offered
7.6.5 Om Pharmaceutical Industries Recent Development
7.7 Gangwal Healthcare
7.7.1 Gangwal Healthcare Company Information
7.7.2 Gangwal Healthcare Business Overview
7.7.3 Gangwal Healthcare Modafinil API Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Gangwal Healthcare Modafinil API Products Offered
7.7.5 Gangwal Healthcare Recent Development
7.8 Alembic Pharmaceuticals Limited
7.8.1 Alembic Pharmaceuticals Limited Company Information
7.8.2 Alembic Pharmaceuticals Limited Business Overview
7.8.3 Alembic Pharmaceuticals Limited Modafinil API Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Alembic Pharmaceuticals Limited Modafinil API Products Offered
7.8.5 Alembic Pharmaceuticals Limited Recent Development
7.9 OrBion Pharmaceuticals
7.9.1 OrBion Pharmaceuticals Company Information
7.9.2 OrBion Pharmaceuticals Business Overview
7.9.3 OrBion Pharmaceuticals Modafinil API Sales, Revenue and Gross Margin (2020-2025)
7.9.4 OrBion Pharmaceuticals Modafinil API Products Offered
7.9.5 OrBion Pharmaceuticals Recent Development
7.10 PROVENTUS LIFE SCIENCES PVT LTD
7.10.1 PROVENTUS LIFE SCIENCES PVT LTD Company Information
7.10.2 PROVENTUS LIFE SCIENCES PVT LTD Business Overview
7.10.3 PROVENTUS LIFE SCIENCES PVT LTD Modafinil API Sales, Revenue and Gross Margin (2020-2025)
7.10.4 PROVENTUS LIFE SCIENCES PVT LTD Modafinil API Products Offered
7.10.5 PROVENTUS LIFE SCIENCES PVT LTD Recent Development
7.11 RR LIFESCIENCES
7.11.1 RR LIFESCIENCES Company Information
7.11.2 RR LIFESCIENCES Business Overview
7.11.3 RR LIFESCIENCES Modafinil API Sales, Revenue and Gross Margin (2020-2025)
7.11.4 RR LIFESCIENCES Modafinil API Products Offered
7.11.5 RR LIFESCIENCES Recent Development
7.12 Maithili Life Sciences Private Limited
7.12.1 Maithili Life Sciences Private Limited Company Information
7.12.2 Maithili Life Sciences Private Limited Business Overview
7.12.3 Maithili Life Sciences Private Limited Modafinil API Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Maithili Life Sciences Private Limited Modafinil API Products Offered
7.12.5 Maithili Life Sciences Private Limited Recent Development
7.13 Gokulendu Life Science
7.13.1 Gokulendu Life Science Company Information
7.13.2 Gokulendu Life Science Business Overview
7.13.3 Gokulendu Life Science Modafinil API Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Gokulendu Life Science Modafinil API Products Offered
7.13.5 Gokulendu Life Science Recent Development
7.14 Gangwal Chemicals
7.14.1 Gangwal Chemicals Company Information
7.14.2 Gangwal Chemicals Business Overview
7.14.3 Gangwal Chemicals Modafinil API Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Gangwal Chemicals Modafinil API Products Offered
7.14.5 Gangwal Chemicals Recent Development
7.15 Bo-Chem Pvt Ltd
7.15.1 Bo-Chem Pvt Ltd Company Information
7.15.2 Bo-Chem Pvt Ltd Business Overview
7.15.3 Bo-Chem Pvt Ltd Modafinil API Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Bo-Chem Pvt Ltd Modafinil API Products Offered
7.15.5 Bo-Chem Pvt Ltd Recent Development
7.16 ZCL Chemicals Limited
7.16.1 ZCL Chemicals Limited Company Information
7.16.2 ZCL Chemicals Limited Business Overview
7.16.3 ZCL Chemicals Limited Modafinil API Sales, Revenue and Gross Margin (2020-2025)
7.16.4 ZCL Chemicals Limited Modafinil API Products Offered
7.16.5 ZCL Chemicals Limited Recent Development
7.17 Nishchem International Pvt. Ltd
7.17.1 Nishchem International Pvt. Ltd Company Information
7.17.2 Nishchem International Pvt. Ltd Business Overview
7.17.3 Nishchem International Pvt. Ltd Modafinil API Sales, Revenue and Gross Margin (2020-2025)
7.17.4 Nishchem International Pvt. Ltd Modafinil API Products Offered
7.17.5 Nishchem International Pvt. Ltd Recent Development
8 Modafinil API Manufacturing Cost Analysis
8.1 Modafinil API Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Modafinil API
8.4 Modafinil API Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Modafinil API Distributors List
9.3 Modafinil API Customers
10 Modafinil API Market Dynamics
10.1 Modafinil API Industry Trends
10.2 Modafinil API Market Drivers
10.3 Modafinil API Market Challenges
10.4 Modafinil API Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Modafinil API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 149
USD 3950.00
(Single User License)
The global Modafinil API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 147
USD 2900.00
(Single User License)
The global Modafinil API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 173
USD 4900.00
(Single User License)
The global market for Modafinil API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 131
USD 3950.00
(Single User License)
The global market for Modafinil API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 110
USD 2900.00
(Single User License)
Modafinil(CAS:68693-11-8) is a central nervous system (CNS) stimulant medication used to treat sleepiness due to narcolepsy, shift work sleep disorder, and obstructive sleep apnea.
Published Date: 2024-02-07
Pages: 115
USD 2900.00
(Single User License)
The global market for Modafinil API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 149
The global Modafinil API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 147
The global Modafinil API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 173
The global market for Modafinil API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 131
The global market for Modafinil API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 110
Modafinil(CAS:68693-11-8) is a central nervous system (CNS) stimulant medication used to treat sleepiness due to narcolepsy, shift work sleep disorder, and obstructive sleep apnea.
Published: 2024-02-07
Pages: 115
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now